Antibacterial agents and methods of screening for the same

Details Antibacterial agents and methods of screening for the same Antibacterial agents and methods of screening for the same

1999-05-20

2002-10-08

McGarry, Sean (Department: 1635)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S243000, C435S252800, C536S023100, C536S024100, C536S024500

Reexamination Certificate

active

06461815

ABSTRACT:

FIELD OF THE INVENTION
The present invention concerns antibacterial and antiviral agents that are directed against tRNA targets, and methods of screening for antibacterial and antiviral agents directed against tRNA targets.
BACKGROUND OF THE INVENTION
Numerous common bacteria are capable of mutating to become resistant to antibiotic agents. Viruses such as HIV are also known to mutate rapidly and thereby avoid immune defense mechanisms. Accordingly, there is a continued need for new antimicrobial agents and antiviral agents.
J. Hill et al., PCT Application WO 9705132, describe compounds that inhibit isoleucyl-tRNA synthetases. The compounds are stated to be useful against a broad spectrum of bacteria, fungi and parasites.
SUMMARY OF THE INVENTION
A first aspect of the present invention is a method of inhibiting microbe propagation. The method comprises inhibiting ribosomal binding of a specific microbial tRNA such as tRNA
lys
SUU
, tRNA
glu
SUG
or tRNA
glu
SUC
(for example, at position 27-43, most preferably position 34, thereof ) in the microbe by an amount sufficient to inhibit microbe propagation. This is achieved by a drug or compound binding to positions 27-43 (one or more positions simultaneously), most preferably position 34 or 37 of the tRNA. Additionally, the compound or drug can inactive (in the microbe) one or more enzymes that are responsible for producing the modification in the specific microbial tRNA that is responsible for the specific binding properties thereof (at positions 27 to 43, preferably positions 34 or 43).
A second aspect of the present invention is a method of inhibiting retrovirus propagation in a host for that retrovirus, wherein that retrovirus primes reverse transcription by binding of a specific host tRNA to retrovirus RNA at at least a pair of separate binding sites. The method comprises inhibiting the binding of the specific host tRNA to the retrovirus RNA at one of the binding sites by an amount sufficient to inhibit propagation of the retrovirus in the host. Advantageously, mutation of the retrovirus RNA to bind an alternate host tRNA for priming of reverse transcription requires a pair of mutations at at least the pair of separate tRNA binding sites in the retrovirus RNA: a low probability event.
A third aspect of the present invention is a method of screening for compounds useful for inhibiting microbial propagation. The method comprises contacting a specific microbial tRNA (for example, tRNA
lys
SUU
) to a ribosome that binds that tRNA in the presence of the test compound, and then determining whether the compound inhibits the binding of that tRNA (e.g., binding of tRNA
lys
SUU
, tRNA
gln
SUG
or tRNA
glu
SUC
at position 27-43, most preferably position 34, thereof) to the ribosome. The inhibition of binding indicates that the test compound is useful for inhibiting microbial propagation. The test compound will generally be binding to position 27-43, individually or in combination, most preferably positions 34 and or 37 of the stated tRNAs. The screening step may be carried out in a host cell, wherein the corresponding host cell tRNA (i.e., the tRNA that binds to the same amino acid) is modified differently as compared to said microbial tRNA at position 27 through 43 thereof (i.e., has a different modification, is not modified where the microbial tRNA is modified, or has the same modification but in a structure not recognized or specifically bound by the test compound).
A fourth aspect of the invention is a method of screening for compounds useful for inhibiting retrovirus propagation in a host for the retrovirus, wherein the retrovirus primes reverse transcription in the host by binding of a specific host tRNA to retrovirus RNA at at least a pair of separate binding sites on the host tRNA. The method comprises contacting the specific host tRNA to the retrovirus RNA in the presence of the test compound, and then determining whether the compound inhibits the binding of the specific host tRNA to the retrovirus RNA in the presence of the test compound. The inhibition of binding indicates that the test compound is useful for inhibiting propagation of the virus in the host. Again, note that mutation of the retrovirus RNA to bind an alternate host tRNA for priming of reverse transcription requires at least a pair of separate mutations at different tRNA binding sites in the retrovirus RNA.


REFERENCES:
patent: 5358862 (1994-10-01), Hardesty et al.
patent: 5556840 (1996-09-01), Suhadolnik et al.
patent: 5629188 (1997-05-01), Shiba et al.
patent: 5674729 (1997-10-01), Wimmer et al.
patent: 5712096 (1998-01-01), Stern et al.
patent: 5821052 (1998-10-01), Chen et al.
patent: 2040615 (1991-05-01), None
patent: 60-196197 (1985-10-01), None
Branch, A.D. TIBS, vol. 23, Feb. 1998, pp. 45-50.*
Stein, C.A. Nature Biotechnology, vol. 17, Aug. 1999, pp. 751-752.*
Flanagan, W.M. Et. Al. Nature Biotechnology, vol. 17, Jan. 1999, 48-52.*
Crooke, S. T. Chapter 1, in Antisense Research and Application, (ed. Stanley Crooke), Springer-Verlag, New York, 1998, pp. 1-50.*
Goldman, M. DTT, vol. 2, No.: 9, Sep. 1997.*
Lloyd, A.W. DTT, vol. 2, No.: 10, Oct. 1997.*
Wess, G. 'DDT, vol. 1, No.: 12, Dec. 1996.*
Von Ahsen, U. et al. Identification of 2′hydroxyl Groups Required for Interaction of a tRNA Anticodon Stem-Loop Region with the Ribosome. RNA, (Jan. 1997), vol. 3, pp. 49-56.*
Stryer, Biochemistry, 3d edition, W.H. Freeman and Co., New York, 1988, pp. 759, Jan. 1997.*
Tamura, Koji, et al., In vitro study ofE.colitRNAArgand tRNALysidentity elements,Nucleic Acids Research,vol. 20, No. 9, pp. 2335-2339 (1992).
Heurgué-Hamard, Valérie, et al., The growth defenct inEscherichia colideficient in peptidyl-tRNA hydrolase is due to starvation for Lys-tRNALys,EMBO Journal,vol. 15, No. 11, pp. 2826-2833 (1996).
McClain, William H.,et al., Nucleotides that determineEscherichia colitRNAArgand tRNALysacceptor identities revealed by analyses of mutant opal and amber suppressor tRNAs,Proc. Natl. Acad. Sci. USA,vol. 87, pp. 9260-9264 (Dec. 1990).
Kumar, Raju K,. et al., Synthesis and studies on the effect of 2-thiouridine and 4-thioruidine on sugar conformation and RNA duplex stability,Nucleic Acids Research,vol. 25, No. 6, pp. 1272-1280 (1997).
Penner, Michael, et al., Phase T4-coded Stp: Double-Edged Effector of Coupled DNA and tRNA-Restriction Systems,J. Mol. Biol.,vol. 249, pp. 857-868 (1995).
Brierley, Ian, et al., Expression of a Coronavirus Ribosomal Frameshift Signal inEscherichia coli: Influence of tRNA Anticodon Modification on Frameshifting,J. Mol. Biol.,vol. 270, pp. 360-373 (1997).
Baldwin, John J., et al., Recent Advances in the Generation of Small-Molecule Combinatorial Libraries: Encoded Split Synthesis and Solid-Phase Synthetic Methodology,Medicinal Research Reviews,vol. 16, No. 5, pp. 391-405 (1996).
Ashraf, S. Salman, et al., Single atom modification (O->S) of tRNA confers ribosome binding,RNA,vol. 5, pp. 188-194 (1999).
Watanbe, Kimitsuna, et al., Unusual anticodon loop structure found inE.colilysine tRNA,Nucleic Acids Research,vol. 22, No. 1, pp. 79-87 (1994).
Sprinzl, Mathis, et al., Compilation of tRNA sequences and sequences of tRNA genes,Nucleic Acids Research,vol. 26. No. 1, pp. 148-153 (1998).
Agris, et al.,Unique Structure Explains Unusual Biochemical Properties of tRNA(Lys)SUU, Presented at the ASBMB 1996 Meeting (Jan. 30, 1996) (abstract).*
Agris, et al.,Unique Structure Explains Human tRNA(LYS3) Selection by HIV Reverse Transcriptase, Presented at the RNA Society 1996 Meeting (Feb. 15, 1996) (abstract).*
Guenther, et al.,Modified RNAs as potential drug targets,Acta Biochemica Polonica, vol. 45, No. 1, pp. 13-18 (1998).

Affiliated with

Also associated with

Rating

Antibacterial agents and methods of screening for the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibacterial agents and methods of screening for the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial agents and methods of screening for the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2944650